Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial

BACKGROUND: Membranous nephropathy leads to end-stage renal disease in more than 20% of patients. Although immunosuppressive therapy benefits some patients, trial evidence for the subset of patients with declining renal function is not available. We aimed to assess whether immunosuppression preserve...

Descripción completa

Detalles Bibliográficos
Autores principales: Howman, Andrew, Chapman, Tracey L, Langdon, Maria M, Ferguson, Caroline, Adu, Dwomoa, Feehally, John, Gaskin, Gillian J, Jayne, David RW, O'Donoghue, Donal, Boulton-Jones, Michael, Mathieson, Peter W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590447/
https://www.ncbi.nlm.nih.gov/pubmed/23312808
http://dx.doi.org/10.1016/S0140-6736(12)61566-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590447/
https://www.ncbi.nlm.nih.gov/pubmed/23312808
http://dx.doi.org/10.1016/S0140-6736(12)61566-9

Ejemplares similares